vaccines

Dynavax cuts staff and cancer R&D, focuses on vaccine

https://pharmaphorum.com/news/dynavax-cuts-staff-and-cancer-rd-focuses-on-vaccine/

Sanofi may airlift medicines into UK after Brexit

https://pharmaphorum.com/news/sanofi-may-airlift-medicines-into-uk-after-brexit/

The long road to vaccination by the MSF

https://pharmaphorum.com/partner-content/the-long-road-to-vaccination-by-the-msf/

Sanofi invests in new Canadian vaccine manufacturing plant

https://pharmaphorum.com/news/sanofi-invests-new-canadian-vaccine-manufacturing-plant/

Call for new restrictions on UK vaccine prices

https://pharmaphorum.com/news/uk-report-calls-new-restrictions-vaccine-prices/

Prokarium raises $10m for ‘game changer’ synthetic bio vaccines

https://pharmaphorum.com/news/prokarium-raises-10m-game-changer-synthetic-bio-vaccines/

Ex-GSK chiefs Witty and Slaoui join biotech investors

https://pharmaphorum.com/news/former-gsk-chiefs-witty-slaoui-join-biotech-investors/

Tipped to hit $1bn, GSK’s Shingrix gains committee approval

https://pharmaphorum.com/news/tipped-hit-1bn-gsks-shingrix-gains-committee-approval/

Sanofi $750m acquisition gives it edge in flu vacccine market

https://pharmaphorum.com/news/sanofi-buys-vaccine-biotech-protein-sciences/

1 2

Close in 10 seconds

Pharmaphorum.com

Search